Aqua Pharma Group
in press and storIES
BREEZE concept wins EUROPEAN SUSTAINABLE AQUACULTURE COMPETITION
The BREEZE initiative which is being developed by a consortium made up of Aqua Pharma Group, Pulcea, the Norwegian University of Science & Technology and the University of Stirling’s Institute of Aquaculture, was one of the four projects chosen by EIT Food for inclusion in its 2021 Business Plan for Sustainable Aquaculture.
BREEZE combines Aqua Pharma Group’s existing hydrogen peroxide treatment with the acoustic based technology pioneered by Pulcea to improve the efficiency of sea lice removal from fish in a gentle treatment. A post-treatment biological clean-up process using enzymes then speeds up the decomposition of the hydrogen peroxide into oxygen and water, making the system suitable for use even in environmentally sensitive areas.
A NEW GOVERNANCE STRUCTURE
AQUA PHARMA GROUP
Paramove producer, Solvay and Norwegian Food Hygiene expert, Aquatiq have concluded a joint-venture agreement regarding Aqua Pharma Group, reinforcing their long-term collaboration to serve aquaculture customers. With this strong shareholder alliance, Aqua Pharma will be able to put an even stronger focus on research & development, new treatment development, for a diverse range of aquaculture segments.
Aqua Pharma INVESTS in START-UP TECHNOLOGY COMPANY Pulcea
The development of an innovative new treatment method to control lice in farmed salmon has moved a step closer with the merging of interests between two experts in the field. Pulcea, which has been developing the use of sound energy to improve the efficiency of existing sea lice treatments, has received investments from Aqua Pharma to accelerate the delivery of its technology, from testing through to commercialisation.